Skip to main content

The impact of empagliflozin on eGFR and albuminuria: results from the ABCD nationwide empagliflozin audit

TSJ Crabtree1,2,3, J Elliott4, A Bickerton5, A Evans6, S Phillips6, K Dhatariya7, I Gallen8, REJ Ryder1; on behalf of ABCD empagliflozin audit contributors9

 

1 Sandwell and West Birmingham Hospitals NHS Trust

2 University Hospitals of Derby and Burton NHS Trust

3 University of Nottingham

4. Sheffield Teaching Hospitals NHS Trust

5 Yeovil District Hospitals NHS Foundation Trust

6 Gloucestershire Hospitals NHS Trust

7 Norfolk and Norwich NHS Trust

8 Royal Berkshire NHS Foundation Trust

9 Association of British Clinical Diabetologists

Related Event
6th Joint Meeting of ABCD & UKKA 2023
Resource taxonomy
Clinical taxonomy
Listing status